Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l
-DOPA treatment and changes in levodopa-induced dyskinesia
1999 ◽
Vol 271
(1)
◽
pp. 33-36
◽
Keyword(s):
2017 ◽
Vol 8
(6)
◽
pp. 1170-1176
◽
2013 ◽
Vol 120
(11)
◽
pp. 1559-1563
◽
1997 ◽
Vol 150
(2)
◽
pp. 123-127
◽
Keyword(s):